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Abstract 
Influenza is a highly contagious respiratory illness caused by influenza viruses with resultant symptoms which include malaise, 
fever, headache, tiredness, cough, sore throat, runny or stuffy nose, diarrhea, vomiting and body aches. Diarrhea and vomiting are 
more common among children than adults. Although most healthy people recover from the influenza without complication, 
young children, pregnant women, adults over 65 years, people with chronic medical conditions (such as asthma, diabetes, or heart 
disease), are at a high risk to develop serious complications which include bacterial pneumonia, sinus problems, ear infections, 
dehydration, and worsening of chronic medical conditions. Disease presentation can vary from mild to severe illness and at times 
can lead to death. Historically, influenza pandemics have proved difficult to manage, clearly highlighting the gravity of a 
potential influenza pandemic. The three influenza pandemics of 1918 to 1919 (Spanish flu), 1957 to 1958 (Asian flu) 1968 to 
1969 (Hong Kong flu) were caused by three different strains of influenza A and resulted in human death tolls of about 100 
million, 1 million and 750,000, respectively.  
The spread of seasonal influenza is usually from person to person when respiratory droplets from infected people are spread 
through a cough or sneeze. The highly pathogenic avian influenza (HPAI) strain H5N1 has emerged as a new global health threat 
of great socioeconomic importance. It has jumped the species barrier to infect humans with grave consequences and has 
decimated large flocks of poultry.  The avian influenza is spread through human contact with infected poultry. However, there is 
the looming threat of human to human transmission of avian influenza which could be devastating. Taken together, the 
development of platforms to study the pathogenicity of influenza A, immune response and to assess the efficacy of vaccines and 
treatment interventions against influenza A is of utmost importance. 
© 2009 Elsevier B.V.    
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1. Study Design 
Ferrets were anesthetized by injection to reduce expulsion/sneeze during intranasal instillation of 1 mL of viral 
stock dilution in phosphate buffered saline (PBS).  A heating pad is used during the hour of anesthesia to reduce 
hypothermia. 
1.1. Viral Stock Quantification Characteristics 
The stocks used in these studies remained the same for each exposure-cohort in order to reduce variability.  Each 
stock produces slightly different characteristics; therefore, inoculation reagents are generated in access of forecasted 
need to ensure additions to studies.  Table 1 shows the viral stock quantification characteristics for 
A/Vietnam/1203/2004 (VN/1203), and Table 2 shows the viral stock quantification characteristics for A/Hong 
Kong/483/1997 (HK/483).  Figure 1 shows a comparison of the viral load by plaque assay and T-5000 Biosensor. 
Table 1.  A/Vietnam/1203/2004 (VN/1203) 
Assay TCID50Plaque EID50
Units/mL 3.6x107 6.5x1071x108
Table 2.  A/Hong Kong/483/1997 (HK/483) 
Assay TCID50Plaque EID50
Units/mL Not 
Done
3.5x1071x107
2. Results 
Decreasing the challenge of VN/1203 
increased duration and titer of virus.  Neither 
olfactory bulbs nor brain had culturable virus 
with the HK/483 challenge.  With the VN/1203 
challenge, turbinates are positive prior to and/or 
initially at a higher titer than olfactory bulb 
and/or brain with both culturable virus and 
nucleic acid detections. 
Quantity and duration of VN/1203 in the brain 
most likely contributes to morbidity due 
neurological complications. 
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2.1. Clinical Sign Onset for VN/1203 
Tables 3 and 4 note the timing of onset of signs and not the duration.  For example, 12 of 12 animals challenged 
with 102 PFU VN/1203 began having loss of appetite from day 3 to 7.  Moribund euthanasias were due to 
neurological complications for ferrets challenged with VN/1203.  Animals challenged with HK/483 were not 
euthanized due to any clinical sign, but at scheduled times; thus, data for clinical signs have not been included.  
Figure 2 shows the affected lung histopathology of 101 VN/1203. 
Table 3.  Onset of clinical sign for 102 PFU challenge 
Table 4.  Onset of clinical sign for 101 PFU challenge 
Appetite loss 12/12
Neurological signs 2/12
Labored breathing
Nasal discharge 11/12
Nasal erythema 12/12
Sneezing 5/12
Ocular discharge 2/12
Conjuctive erythema 2/12
Loose stool 9/12
Decreased activity 9/12
Appetite loss 11/12
Neurological signs 7/12
Labored breathing 7/12
Nasal discharge 10/12
Nasal erythema 11/12
Sneezing 5/12
Ocular discharge 4/12
Conjuctive erythema 3/12
Loose Stool 11/12
Decreased activity 9/12
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Figure 2.  Affected lung histopathology of 101 VN/1203. 
The following histopathology observations were noted.  Pneumonia onset presented at 2–3 days post challenge.  
Moderate to severe meningioencephalitis was observed (onset ~ 4 days post challenge; inflammation observed to 
day 28).  Findings were similar for the 102 PFU VN/1203 challenge. 
2.2. Preliminary IHC 
Tissues were stained for HPAI nuclear protein, which were found in the nasal passage, brain, spleen, lymph node, 
thymus, and liver. 
Animals were euthanized due to neurological complications more often than for other criteria.  In addition to 
paralysis, weight loss and hypothermia may prove to be significant endpoints for vaccine and therapeutic studies 
where pneumonic disease causes the moribund state.  Figure 3 shows the Kaplan-Meier Curve for VN/1203.
Figure 3.  Kaplan-Meier Curve for VN/1203. 
3. Conclusions 
The ferret model is deemed sufficient to 
examine human vaccines and treatments 
for avian influenza.  Lower (perhaps more 
natural transmission) doses predominantly 
direct a neurological death in the ferret.  
Brain involvement is likely due to passage 
of virus from nasal passage to brain rather 
than from blood to brain.   
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Protection from lower doses of fatal avian influenza may depend on preventing early infection of nasal passages, 
olfactory bulbs, and the brain. 
3.1. Future Work 
• Determine vaccine efficacy 
• Provide more evidence for neural/CSF dissemination of VN/1203 
Figure 4 shows the proposed viral dissemination route. 
Figure 4. Proposed viral dissemination route. 
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